Vir Biotechnology (VIR) Trades Higher in Sympathy with Janux Therapeutics (JANX)

Vir Biotechnology Inc. (NASDAQ: VIR) Trades Higher in Sympathy with Janux Therapeutics (NASDAQ: JANX)

• Janux Therapeutics Surges 40% After Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Varonis Systems (VRNS) call put ratio 4.4 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 6.4%
• Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi